MXBio is a venture-certified company established in June 2018.
bio/medical services.We are developing dental specialty drugs in the dental field. The product currently being developed is the specialty drug 'PeriMedi Dental Ointment' developed for the purpose of treating peri-implant inflammation.
Through clinical trials, it has been confirmed that there is a therapeutic superiority in peri-implant inflammation compared to existing products, and it is currently preparing for domestic product approval.
There has been no case of developing complex antibiotic ointments worldwide, and it is expected to achieve good results when entering the market because it has confirmed its superiority over existing products through clinical and preclinical trials.
It is already holding pre-contract and delivery-related meetings with China (CCdental) and the United States (Tri-state community healthcare clinical center) in the pre-production stage.
PeriMedi was developed for humans, but it can also be applied as an animal periodontal disease drug.
Through animal experiments, it was confirmed that it is effective against inflammation relief and severe periodontal disease symptoms, and it was confirmed that it can be applied as an animal drug.
With one development item, you can enter the market of two people and animals together.